Clinical Trials Browser

Phase NA × Accessory Nerve Injuries × Therapeutics × Clear all

NCT02647021 2024-01-03

TARGET

Phase NA Completed

Fatigue, Head and Neck Neoplasms, Motor Activity, Accessory Nerve Injuries